On this page

CMS RVU26D · Effective 2026-10-01

Q4313 Wound product Medicare reimbursement rates in Massachusetts

Dermabind FM is a wound-covering skin substitute product reported by square centimeter with a qualifying wound application procedure. Compare Q4313 office and facility rates across CMS payment localities in Massachusetts.

Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.

What does Medicare pay for Q4313 in Massachusetts?

Massachusetts has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.

Office / nonfacility

$134.00–$151.95

2 of 2 localities have a supported rate.

Lowest: Rest Of Massachusetts

Highest: Metropolitan Boston

A spread of $17.95 per service.

Facility setting

No supported rate

These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.

Find Q4313 in your payment locality →

Skin substitute product

About Q4313: Dermabind FM wound product

Dermabind FM is a wound-covering skin substitute product reported by square centimeter with a qualifying wound application procedure.

Q4313 identifies Dermabind FM supplied for wound coverage, with quantity measured in square centimeters. It represents the product, not wound preparation or the clinician’s application service. Wound-care physicians, surgeons, and other clinicians treating open wounds may use the product in office or hospital outpatient settings. The product code follows the Dermabind FM used, rather than the wound’s location or a particular diagnosis.

Report Q4313 only with a primary wound application procedure, selecting the applicable procedure based on the treated site and wound area. The record should identify Dermabind FM and support the quantity reported in square centimeters. CMS treats Q4313 as an add-on: payment is made with the primary procedure and within that procedure’s global period. CMS classifies the code as technical-component-only, with interpretation represented by a separate code.

CMS billing rules for Q4313

Global period
Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
Professional and technical components
Technical-component-only code: a separate code covers interpretation.

Where the value comes from

  • Work RVU0.00 · 0%
  • Practice expense (office) RVU3.81 · 100%
  • Malpractice RVU0.00 · 0%

11.1K

Medicare services in 2024 · #1424 by national volume

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Q4313 compared with similar codes

Office rates for Massachusetts, from the same CMS release.

Q4312

Wound product

Acesso AC, per square centimeter

$134.00–$151.95

Q4312 identifies Acesso AC, not Dermabind FM. Select the product-specific code for the product supplied.

Q4314

Wound product

Reeva, per square centimeter

$134.00–$151.95

Q4314 identifies Reeva. Its per-square-centimeter unit does not make it interchangeable with Dermabind FM.

Q4310

Procenta, per 100 mg

No office rate

Q4310 identifies Procenta and is reported per 100 mg; Q4313 identifies Dermabind FM and is measured per square centimeter.

Compare Q4313 by payment locality

Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.

2 of 2 payment localities

Office and facility base rates · shared scale starting at $0

Need rates for a whole code list?

Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.

Explore fee-sheet early access →

Q4313 billing questions

Does Q4313 include the wound application service?

No. Q4313 identifies the Dermabind FM product; report it with the appropriate primary wound application procedure, such as a code in the 15271–15278 series.

How do I select the primary application code?

Choose the application procedure based on the wound site and treated area. For example, 15271 and 15275 apply to different anatomic site groupings.

How many units should I report?

Report the Dermabind FM quantity in square centimeters. Documentation should support the product and the amount used.

Is interpretation included in Q4313?

CMS classifies Q4313 as technical-component-only; a separate code covers interpretation.

Can I report Q4313 by itself?

No. CMS identifies it as an add-on code, so it is billed with a primary procedure and paid within that procedure’s global period.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.

Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.

RVUs for Q4313PPRRVU2026_Oct_nonQPP.csv, line 18,400 (RVU26D)